Literature DB >> 9834084

Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II.

J Calvo1, J M Vildà, L Places, M Simarro, O Padilla, D Andreu, K S Campbell, C Aussel, F Lozano.   

Abstract

CD5 is a lymphocyte surface glycoprotein with a long cytoplasmic domain suitable for phosphorylation and signal transduction, which is involved in the modulation of Ag-specific receptor-mediated activation and differentiation signals. In this study, we use Jurkat T cell transfectants of CD5 cytoplasmic tail mutants to reveal phosphorylation sites relevant to signal transduction. Our results show that casein kinase II (CKII) is responsible for the constitutive phosphorylation of CD5 molecules at a cluster of three serine residues located at the extreme C terminus (S458, S459, and S461). Furthermore, the yeast two-hybrid system demonstrates the specific association between the C-terminal regions of the CD5 cytoplasmic tail and the regulatory beta subunit of CKII. We demonstrate that CKII associates with and phosphorylates the C-terminal region of CD5, a conserved domain known to be relevant for the generation of second lipid messengers, and thereby enables at least one component of its signaling function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834084

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  CD5, an important regulator of lymphocyte selection and immune tolerance.

Authors:  Chander Raman
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  CD5 enhances Th17-cell differentiation by regulating IFN-γ response and RORγt localization.

Authors:  Donald J McGuire; Amber L Rowse; Hao Li; Binghao J Peng; Christine M Sestero; Kevin S Cashman; Patrizia De Sarno; Chander Raman
Journal:  Eur J Immunol       Date:  2014-01-16       Impact factor: 5.532

3.  CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system.

Authors:  Robert C Axtell; Liang Xu; Scott R Barnum; Chander Raman
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

4.  Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.

Authors:  Uri Rozovski; David M Harris; Ping Li; Zhiming Liu; Preetesh Jain; Ivo Veletic; Alessandra Ferrajoli; Jan Burger; Susan O'Brien; Prithviraj Bose; Philip Thompson; Nitin Jain; William Wierda; Michael J Keating; Zeev Estrov
Journal:  Mol Cancer Res       Date:  2017-01-27       Impact factor: 5.852

5.  The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells.

Authors:  Amanda K Purdy; Diana A Alvarez Arias; Jennifer Oshinsky; Ashley M James; Ilya Serebriiskii; Kerry S Campbell
Journal:  J Immunol       Date:  2014-09-19       Impact factor: 5.422

6.  CD5 (OKT1) augments CD3-mediated intracellular signaling events in human T lymphocytes.

Authors:  S M Berney; T Schaan; R E Wolf; D L Kimpel; H van der Heyde; T P Atkinson
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

7.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Authors:  Jorge Vera; Rafael Fenutría; Olga Cañadas; Maite Figueras; Rubén Mota; Maria-Rosa Sarrias; David L Williams; Cristina Casals; José Yelamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

8.  Ability of CK2beta to selectively regulate cellular protein kinases.

Authors:  Birgitte B Olsen; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

9.  CD5-dependent CK2 activation pathway regulates threshold for T cell anergy.

Authors:  Christine M Sestero; Donald J McGuire; Patrizia De Sarno; Emily C Brantley; Gloria Soldevila; Robert C Axtell; Chander Raman
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

10.  A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation.

Authors:  Johannes Breuning; Marion H Brown
Journal:  Immunology       Date:  2018-12-10       Impact factor: 7.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.